Powered by LiquidBiopsy, ClearID provides a minimally-invasive tool to monitor cancer patients, enabling more frequent testing and real-time molecular profiling of tumor DNA. Leveraging patented cell enrichment technology, the test analyzes patients' individual mutations to match them with targeted cancer therapies and clinical trials.
Kami menggunakan cookies untuk rekomendasi konten, pengukuran traffic, dan iklan yang dipersonalisasi. Dengan penggunaan website kami, anda sudah setuju dengan and .